IL86334A - Pharmaceutical compositions for transdermal delivery of a pure enantiomer - Google Patents

Pharmaceutical compositions for transdermal delivery of a pure enantiomer

Info

Publication number
IL86334A
IL86334A IL86334A IL8633488A IL86334A IL 86334 A IL86334 A IL 86334A IL 86334 A IL86334 A IL 86334A IL 8633488 A IL8633488 A IL 8633488A IL 86334 A IL86334 A IL 86334A
Authority
IL
Israel
Prior art keywords
transdermal delivery
pharmaceutical compositions
pure enantiomer
enantiomers
compositions
Prior art date
Application number
IL86334A
Other languages
English (en)
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IL86334A publication Critical patent/IL86334A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL86334A 1987-06-12 1988-05-11 Pharmaceutical compositions for transdermal delivery of a pure enantiomer IL86334A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6184287A 1987-06-12 1987-06-12

Publications (1)

Publication Number Publication Date
IL86334A true IL86334A (en) 1992-09-06

Family

ID=22038497

Family Applications (1)

Application Number Title Priority Date Filing Date
IL86334A IL86334A (en) 1987-06-12 1988-05-11 Pharmaceutical compositions for transdermal delivery of a pure enantiomer

Country Status (16)

Country Link
EP (1) EP0294601B1 (xx)
JP (1) JP2654092B2 (xx)
KR (1) KR970000506B1 (xx)
AT (1) ATE84714T1 (xx)
AU (1) AU609142B2 (xx)
CA (1) CA1305418C (xx)
DE (1) DE3877630T2 (xx)
DK (1) DK171746B1 (xx)
ES (1) ES2043719T3 (xx)
GR (1) GR3006938T3 (xx)
IE (1) IE62735B1 (xx)
IL (1) IL86334A (xx)
NO (1) NO178096C (xx)
NZ (1) NZ224891A (xx)
PT (1) PT87704B (xx)
ZA (1) ZA884186B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5045553A (en) * 1987-06-24 1991-09-03 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
US6075024A (en) 1991-11-27 2000-06-13 Sepracor Inc. Methods for treating infection using optically pure (S)-lomefloxacin
US5476854A (en) * 1991-11-27 1995-12-19 Sepracor Inc. Methods and compositions for treating bacterial infection using optically pure (R)-lomefloxacin
US5834496A (en) * 1991-12-02 1998-11-10 Sepracor, Inc. Methods for treating hypertension using optically pure S(-) felodipine
WO1994010986A1 (en) * 1992-11-09 1994-05-26 Pharmetrix Corporation Transdermal delivery of ketorolac
NZ530227A (en) * 2001-06-18 2006-09-29 Noven Pharma Enhanced drug delivery in transdermal systems
DK1628663T3 (da) 2003-05-15 2010-03-08 Roskamp Res Llc Fremgangsmåde til fremstilling af medikamenter til reduktion af amyloid-aflejring, amyloid-neurotoksicitet og mikrogliose
TWI500422B (zh) 2007-10-05 2015-09-21 Alzheimer S Inst Of America Inc 以（－）－尼代地平（ｎｉｌｖａｄｉｐｉｎｅ）對映異構物減低類澱粉沉積、類澱粉神經毒性及微神經膠細胞增生之方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284634A (en) * 1975-07-02 1981-08-18 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, and pharmaceutical method of the same
US4338322A (en) * 1975-07-02 1982-07-06 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, pharmaceutical compositions containing same and methods of effecting vasodilation using same
CA1117117A (en) * 1978-10-10 1982-01-26 Fujisawa Pharmaceutical Co., Ltd. 2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same
JPS6016917A (ja) * 1983-07-08 1985-01-28 Yamanouchi Pharmaceut Co Ltd 塩酸ニカルジピンまたはニフエジピンの軟膏剤
JPS60258179A (ja) * 1984-06-04 1985-12-20 Yamanouchi Pharmaceut Co Ltd Ｙｍ−０９７３０のジアステレオマ−ａの右旋性光学異性体またはその酸付加塩，該化合物の製造方法および該化合物からなる医薬
DE3419128A1 (de) * 1984-05-23 1985-11-28 Bayer Ag, 5090 Leverkusen Dihydropyridinpraeparate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
PT87704B (pt) 1993-03-31
EP0294601A3 (en) 1989-10-11
EP0294601A2 (en) 1988-12-14
NO882559D0 (no) 1988-06-10
ES2043719T3 (es) 1994-01-01
AU609142B2 (en) 1991-04-26
DK316788A (da) 1988-12-13
JP2654092B2 (ja) 1997-09-17
CA1305418C (en) 1992-07-21
KR890000090A (ko) 1989-03-11
IE62735B1 (en) 1995-02-22
EP0294601B1 (en) 1993-01-20
DE3877630D1 (de) 1993-03-04
DE3877630T2 (de) 1993-06-03
NZ224891A (en) 1992-06-25
JPS6413024A (en) 1989-01-17
GR3006938T3 (xx) 1993-06-30
ATE84714T1 (de) 1993-02-15
DK316788D0 (da) 1988-06-10
NO178096B (no) 1995-10-16
PT87704A (pt) 1988-07-01
NO178096C (no) 1996-01-24
IE881749L (en) 1988-12-12
NO882559L (no) 1988-12-13
AU1761088A (en) 1988-12-15
KR970000506B1 (ko) 1997-01-13
DK171746B1 (da) 1997-05-05
ZA884186B (en) 1989-03-29

Similar Documents

Publication Publication Date Title
HUT43952A (en) Process for preparing pharmaceuticals comprising (-)-3-(3,4-dihydroxyphenyl)-l-alanine-methylester
SI0725779T1 (xx)
GR850507B (xx)
IL86334A (en) Pharmaceutical compositions for transdermal delivery of a pure enantiomer
ZA884418B (en) Pharmaceutical dosage unit
ZA872128B (en) Chlorpheniramine therapy
CS318690A3 (en) Pharmaceutical composition usable for depression therapy
PH22077A (en) Spasmolytically active (+) s enantiomer of secoverine
EP0348664A3 (en) Pharmaceutical compositions containing monoacetoacetins for treating tumours
AU575067B2 (en) Salts of l or (s)-3-(3,4-dihydroxyphenyl)-2- methylalanine esters
ATE84975T1 (de) Pharmazeutische praeparate.

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired